Benjamin F. Edwards & Company’s Esperion Therapeutics ESPR Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1K	Hold	325	–	–	﹤0.01%	2086
2024 Q1	$1K	Hold	325	–	–	﹤0.01%	2073
2023 Q4	$1K	Hold	325	–	–	﹤0.01%	2032
2023 Q3	$0	Hold	325	–	–	﹤0.01%	1760
2023 Q2	$0	Hold	325	–	–	﹤0.01%	1780
2023 Q1	$1K	Hold	325	–	–	﹤0.01%	1720
2022 Q4	$2K	Hold	325	–	–	﹤0.01%	1721
2022 Q3	$2K	Sell	325 -50	-13%	-$343	﹤0.01%	1704
2022 Q2	$2K	Hold	375	–	–	﹤0.01%	1678
2022 Q1	$2K	Hold	375	–	–	﹤0.01%	1650
2021 Q4	$2K	Hold	375	–	–	﹤0.01%	1628
2021 Q3	$5K	Hold	375	–	–	﹤0.01%	1518
2021 Q2	$8K	Hold	375	–	–	﹤0.01%	1417
2021 Q1	$11K	Hold	375	–	–	﹤0.01%	1326
2020 Q4	$10K	Buy	+375	New	+$11.2K	﹤0.01%	1274
2018 Q1	–	Sell	-152	Closed	-$10K	–	1626
2017 Q4	$10K	Hold	152	–	–	﹤0.01%	1196
2017 Q3	$8K	Buy	+152	New	+$7.33K	﹤0.01%	1221

Other funds holding ESPR

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return